Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Rukia Isabel Yosuf

Rukia Isabel Yosuf

Medicine and Life Sciences USA

Alan J. Stewart

Alan J. Stewart

University of St Andrews UK

Thomas S Helling

Thomas S Helling

Professor, Department of Surgery University of Mississippi USA

Mayank Singhal

Mayank Singhal

Cape Fear Valley Hospital USA

Jason D. Gardner

Jason D. Gardner

Louisiana State University Health Sciences Center USA

Ellie Wright

Ellie Wright

EGW Research Institute LLC USA

Ralph Abraham

Ralph Abraham

London Medical College UK

Gerald C. Hsu

Gerald C. Hsu

eclaire MD Foundation USA

Recommended Global Diabetes & Endocrinology Webinars & Conferences

Asia Pacific & Middle East

ENDOCRINOLOGY MEET 2024

About Conference


On behalf of the organizing committee, it is with great pleasure and anticipation that we extend a warm welcome to you for the 7th Annual Meeting on Diabetes and Endocrinology, scheduled to take place in the captivating city of Paris, France, on September 09-10, 2024. Endocrinology Meet 2024 promises to be a remarkable platform for exchanging cutting-edge research, innovative ideas, and best practices in the field of diabetes and endocrinology. We look forward to your invaluable contributions and the opportunity to forge enduring connections in this vibrant scientific community. Prepare to be inspired, enlightened, and empowered as we embark on this journey together towards enhancing patient care and shaping the future of diabetes and endocrinology. We are excited to facilitate dynamic discussions, foster collaborations, and ultimately advance our collective understanding and management of these critical health issues.

Scope and importance

The Endocrinology Meet 2024 conference serves as a vital platform for professionals in the field to explore the latest developments and challenges in endocrinology. This conference offers a comprehensive scope covering diverse topics such as diabetes, thyroid disorders, hormonal imbalances, reproductive health, and more. By bringing together clinicians, researchers, educators, and industry leaders, it facilitates interdisciplinary collaboration, fosters knowledge exchange, and promotes innovative approaches to diagnosis, treatment, and prevention. The conference's importance lies in its ability to drive forward-thinking discussions, share cutting-edge research findings, and ultimately advance our understanding and management of endocrine disorders.

Why to attend?

Attending the Endocrinology Meet 2024 conference is essential for anyone involved in the field of endocrinology. This gathering offers a unique platform to stay updated on the latest research, breakthroughs, and advancements in endocrine disorders and treatments. Through engaging presentations, interactive sessions, and networking opportunities, attendees can expand their knowledge, exchange ideas, and establish valuable connections with peers and experts.

Who can attend?

The Endocrinology Meet 2024 conference welcomes a diverse audience, including endocrinologists, researchers, clinicians, healthcare professionals, educators, students, and industry representatives. With sessions tailored to various interests and expertise levels, attendees can engage in discussions, share insights, and stay updated on the latest advancements in the field.

Target Audience

  • Endocrinologists
  • Diabetologists
  • Diabetes educators
  • Researchers in endocrinology and diabetes
  • Clinical researchers
  • Healthcare professionals
  • Dietitian
  • Neurologists
  • Ophthalmologist
  • Cardiologists
  • Nephrologists
  • Diabetes societies & associations
  • Medical & Pharmaceutical companies
  • Primary care physicians
  • Nurse practitioners
  • Pharmacists
  • Students
  • Industry professionals
  • Policy makers

Sessions

Track 1: Overview of Diabetes

Providing a comprehensive understanding of diabetes mellitus, covering its epidemiology, etiology, pathophysiology, and diagnostic criteria to lay the foundation for subsequent discussions on management and complications.

  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes
  • Diabetes Mellitus

Track 2: Diabetic Complications

Exploring the multifaceted complications arising from diabetes, including microvascular (retinopathy, nephropathy) and macrovascular (cardiovascular disease, neuropathy) complications, alongside strategies for prevention, early detection, and optimal management.

  • Foot Complications
  • Gastroparesis
  • Hypoglycemia

Track 3: Obesity-Related Diabetes

Investigating the intricate relationship between obesity and diabetes, focusing on the mechanisms linking adiposity, insulin resistance, and metabolic dysfunction, and exploring tailored approaches to managing diabetes in the context of obesity.

  • Beta Cell Dysfunction
  • Inflammation
  • Dyslipidemia
  • Central Obesity

Track 4: Insulin Therapy

Delving into the principles, modalities, and advancements in insulin replacement therapy for diabetes management, encompassing insulin types, administration techniques, dose titration, and strategies to optimize glycemic control while minimizing hypoglycemia and other adverse effects.

Track 5: Pediatric Endocrinology

Addressing the unique aspects of diagnosing, treating, and managing endocrine disorders in pediatric populations, encompassing growth disorders, puberty-related issues, congenital adrenal hyperplasia, diabetes, and other hormone-related conditions.

  • Growth Disorders
  • Diabetes in Children
  • Genetic Syndromes

Track 6: Neuroendocrinology

Exploring the intricate interplay between the endocrine system and the central nervous system, elucidating neuroendocrine pathways, and their roles in regulating homeostasis, stress responses, mood, behavior, and reproductive function.

  • Neuroendocrine Disorders
  • Stress Response
  • Neurotransmitters
  • Hypothalamus-Pituitary Axis
  • Hormonal Regulation

Track 7: Endocrine Glands

Delving into the latest advancements in basic and translational research focused on elucidating the physiology, pathophysiology, and therapeutic targets of endocrine glands, spanning from molecular mechanisms to clinical applications.

  • Types of Glands
  • Molecular Biology
  • Signal Transduction
  • Therapeutics

Track 8: Reproductive Endocrinology

Investigating the hormonal regulation of reproductive function, fertility, menstrual health, and sexual development, as well as the diagnosis and treatment of disorders affecting the reproductive system in both men and women.

  • Menstrual Disorders
  • Polycystic Ovary Syndrome
  • Infertility
  • Hormone Replacement Therapy
  • Reproductive Endocrine Disorders
  • Assisted Reproductive Technologies

Track 9: Thyroid Imbalance Insights

Providing insights into the spectrum of thyroid disorders, including hypothyroidism, hyperthyroidism, thyroid nodules, and thyroid cancer, exploring diagnostic modalities, treatment options, and considerations for personalized management.

  • Autoimmune Thyroid Disorders
  • Treatment Options
  • Thyroid Function Tests

Track 10: Endocrine Disorders

Surveying the landscape of various endocrine disorders, beyond diabetes and thyroid conditions, including adrenal, pituitary, gonadal, and parathyroid disorders, highlighting their clinical presentations, diagnostic approaches, and management strategies.

  • Pancreatic Disorders
  • Genetic Endocrine Disorders
  • Diabetes Mellitus

Track 11: Metabolic Syndrome

Investigating the constellation of metabolic abnormalities underlying metabolic syndrome, including central obesity, dyslipidemia, hypertension, and insulin resistance, and discussing the implications for cardiovascular risk assessment and targeted interventions.

  • Abdominal Obesity
  • Dyslipidemia
  • High Blood Sugar

Track 12: Mental Health in Endocrine Care

Examining the bidirectional relationship between mental health disorders and endocrine conditions, addressing the impact of hormonal imbalances on mood, cognition, and behavior, and integrating mental health considerations into comprehensive endocrine care.

  • Psychological Impact
  • Emotional Well-being
  • Psychiatric Comorbidities

Track 13: Endocrine Oncology

Scrutinizing the diagnosis, staging, treatment modalities, and multidisciplinary management of endocrine-related malignancies, encompassing thyroid, adrenal, pituitary, and neuroendocrine tumors, and addressing emerging therapeutic approaches and challenges.

  • Thyroid Cancer
  • Adrenal Tumors
  • Pituitary Tumors
  • Parathyroid Cancer
  • Neuroendocrine Tumors
  • Endocrine Pancreatic Tumors
  • Surgical Interventions

Track 14: Endocrine Genomics Essentials

Providing foundational insights into the role of genetics and genomics in shaping endocrine function, disorders, and personalized therapeutic strategies, highlighting key genetic variants, genomic technologies, and implications for precision medicine.

  • Genetic Screening
  • Gene Expression Profiling
  • Pharmacogenomics
  • Genetic Counseling
  • Polygenic Risk

Track 15: Radiological Approaches in Endocrinology

Exploring the utility, indications, and interpretations of various radiological imaging modalities in diagnosing and monitoring endocrine disorders, from ultrasound to nuclear medicine, and discussing advancements in radiological techniques and their applications.

  • Imaging Modalities
  • Functional Imaging
  • Image-Guided Interventions
  • Multimodal Imaging

Track 16: Precision Medicine in Endocrine Practice

Delving into the paradigm shift toward personalized approaches to diagnosing, treating, and managing endocrine disorders, leveraging genomic, molecular, and clinical data to tailor interventions to individual patient characteristics and optimize outcomes.

Track 17: Dietary Interventions in Endocrinology

Investigating the impact of dietary factors and interventions on endocrine health, including nutritional approaches to diabetes management, weight loss, metabolic syndrome, and other hormone-related conditions, and exploring dietary guidelines and lifestyle modifications.

  • Diabetes Management
  • Weight Management
  • Calcium and Vitamin D Supplementation
  • Medical Nutrition Therapy
  • Behavioral Counseling

Track 18: Remote Endocrine Care

Exploring the evolving landscape of telemedicine and remote monitoring in delivering endocrine care, encompassing virtual consultations, telehealth platforms, digital health technologies, and their implications for improving access, convenience, and patient outcomes.

Track 19: Endo Case Challenges

Engaging participants in interactive case-based discussions to navigate complex clinical scenarios and diagnostic dilemmas encountered in endocrine practice, fostering critical thinking, problem-solving skills, and collaborative decision-making in real-world contexts.

Participation Benefits

  • Attend keynote presentations by esteemed researchers.
  • Gain access to all sessions and networking opportunities.
  • Receive global recognition for research and profile.
  • Publish abstracts in international journals with unique DOIs.
  • Obtain discounts for publishing articles in open-access journals.
  • Receive handbooks and conference kits.
  • Network with prominent figures from around the globe.
  • Learn and expand knowledge from top professionals.
  • Receive certified participation for abstracts.
  • Establish global connections for research ideas and professional growth.

Participation categories:

  • Keynote Speaker: Deliver a presentation lasting 45-50 minutes, sharing insights as a prominent figure in the field.
  • Speaker (Oral Presentation): Present findings for 25-30 minutes, showcasing individual research or expertise.
  • Speaker (Workshop): Lead a workshop for 45-50 minutes, providing interactive learning experiences.
  • Speaker (Special Session): Contribute to a special session for 45-50 minutes, alongside fellow experts.
  • Speaker (Symposium): Engage in a symposium for more than 45 minutes, collaborating with multiple presenters.
  • Delegate (Registration Only): Access all sessions and benefits upon registration.
  • Poster Presenter: Showcase research through poster presentations, enjoying delegate benefits.
  • Remote Attendance: Participate via video or e-poster presentation.
  • Exhibitor: Display company products through booked booths of varying sizes.
  • Media Partner, Sponsor, and Collaborator: Collaborate with the event, offering support and visibility.

Market Analysis

Endocrinology Meet 2024 will feature the latest developments in research, diagnosis and prevention and management of diabetes, new insulin analogues and new technologies and devices for diabetic prevention, and for treating obesity and many more. Not only will this innovative conference enhance your practical and theoretical knowledge, it will provide you with the unique

DM affects an estimated 29.1 million people in the United States and is the 7th leading cause of death. It increases the all-cause mortality rate 1.8 times compared to persons without diagnosed diabetes. It Increases the risk of heart attack by 1.8 times, in addition to these human costs, the estimated total financial cost of DM in the United States in 2012 was $245 billion, which includes the costs of medical care, disability, and premature death.

The importance of both diabetes and their comorbidities will continue to increase as the population ages. Therapies that have proven to reduce microvascular and macrovascular complications will need to be assessed considering the newly identified comorbidities. 

Market value on Diabetic Research:

More than 150 million expected to have diabetes by 2040

According to the International Diabetes Federation, more than 100 million people have diabetes in China, more than any other country in the world. Recently the number of cases has increased rapidly in recent years and it is expected to reach 151 million by 2040.

To Collaborate Scientific Professionals around the World

Conference Date September 09-10, 2024

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

Journal of Obesity & Weight Loss Therapy Journal of Pituitary Research & Treatment Journal of Autacoids and Hormones

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

Keytopics

  • Acromegaly
  • Addison's Disease
  • Adrenal Crisis
  • Adrenal Tumors
  • Adrenaline
  • Adrenocorticotropic Hormone
  • Aldosterone
  • Amenorrhea
  • Androgens
  • Andropause
  • Calcitonin
  • Congenital Adrenal Hyperplasia
  • Corticotropin-releasing Hormone
  • Cortisol
  • Cushing's Syndrome
  • Delayed Puberty
  • Diabetes Insipidus
  • Diabetic Foot
  • Diabetic Ketoacidosis
  • Diabetic Nephropathy
  • Diabetic Neuropathy
  • Diabetic Retinopathy
  • Dwarfism
  • Estrogen
  • Follicle-stimulating Hormone
  • Galactorrhea
  • Gestational Diabetes
  • Gestational Diabetes Insipidus
  • Gestational Hyperparathyroidism
  • Gestational Hyperprolactinemia
  • Gestational Hypertension
  • Gestational Hyperthyroidism
  • Gestational Hypoparathyroidism
  • Gestational Hypothyroidism
  • Gestational Thyrotoxicosis
  • Gigantism
  • Glucagon
  • Glucocorticoids
  • Goiter
  • Gonadotropin
  • Gonads
  • Graves' Disease
  • Growth Hormone
  • Gynecomastia
  • Hashimoto's Thyroiditis
  • Hirsutism
  • Hyperaldosteronism
  • Hypercalcemia
  • Hyperglycemia
  • Hypergonadotropic Hypogonadism
  • Hyperinsulinism
  • Hyperparathyroidism
  • Hyperprolactinemia
  • Hypertension
  • Hyperthyroid Myopathy
  • Hypoaldosteronism
  • Hypocalcemia
  • Hypoglycemia
  • Hypoglycemic Coma
  • Hypogonadism
  • Hypogonadotropic Hypogonadism
  • Hypoinsulinism
  • Hypoparathyroidism
  • Hypopituitarism
  • Hypoprolactinemia
  • Hypotension
  • Hypothyroid Coma
  • Hypothyroid Myopathy
  • Insulin Resistance
  • Lipodystrophy
  • Luteinizing Hormone
  • Melatonin
  • Menopause
  • Mineralocorticoids
  • Myxedema Coma
  • Neuroendocrine Tumors
  • Osteopenia
  • Osteoporosis
  • Ovarian Cysts
  • Oxytocin
  • Pancreatitis
  • Paraganglioma
  • Parathyroid Hormone
  • Pituitary Adenoma
  • Pituitary Disorders
  • Polycystic Ovary Syndrome
  • Precocious Puberty
  • Progesterone
  • Prolactin
  • Somatostatin
  • Testicular Cancer
  • Testosterone
  • Thyroid Nodules
  • Thyroid-stimulating Hormone
  • Thyrotoxicosis
  • Thyrotropin-releasing Hormone
  • Thyroxine
  • Triiodothyronine
  • Vasopressin